219 related articles for article (PubMed ID: 19739037)
1. The impact of the fibrinolytic system on the risk of venous and arterial thrombosis.
Meltzer ME; Doggen CJ; de Groot PG; Rosendaal FR; Lisman T
Semin Thromb Hemost; 2009 Jul; 35(5):468-77. PubMed ID: 19739037
[TBL] [Abstract][Full Text] [Related]
2. Fibrinolysis and the risk of venous and arterial thrombosis.
Meltzer ME; Doggen CJ; de Groot PG; Rosendaal FR; Lisman T
Curr Opin Hematol; 2007 May; 14(3):242-8. PubMed ID: 17414214
[TBL] [Abstract][Full Text] [Related]
3. [Parameters related to fibrinolysis and their meanings].
Urano T; Suzuki Y
Rinsho Byori; 2011 Jul; 59(7):703-8. PubMed ID: 21874797
[TBL] [Abstract][Full Text] [Related]
4. Plasmin generation plays different roles in the formation and removal of arterial and venous thrombus in mice.
Matsuno H; Kozawa O; Okada K; Ueshima S; Matsuo O; Uematsu T
Thromb Haemost; 2002 Jan; 87(1):98-104. PubMed ID: 11848464
[TBL] [Abstract][Full Text] [Related]
5. Decreased Plasma Fibrinolytic Potential As a Risk for Venous and Arterial Thrombosis.
Lisman T
Semin Thromb Hemost; 2017 Mar; 43(2):178-184. PubMed ID: 27472427
[TBL] [Abstract][Full Text] [Related]
6. [Characteristics of the fibrinolytic system in the newborn].
Schlegel N; Hurtaud-Roux MF; Beaufils F
Ann Pediatr (Paris); 1993 Feb; 40(2):70-4. PubMed ID: 8457135
[TBL] [Abstract][Full Text] [Related]
7. Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1.
Meltzer ME; Lisman T; de Groot PG; Meijers JC; le Cessie S; Doggen CJ; Rosendaal FR
Blood; 2010 Jul; 116(1):113-21. PubMed ID: 20385790
[TBL] [Abstract][Full Text] [Related]
8. Hypofibrinolysis is a risk factor for arterial thrombosis at young age.
Guimarães AH; de Bruijne EL; Lisman T; Dippel DW; Deckers JW; Poldermans D; Rijken DC; Leebeek FW
Br J Haematol; 2009 Apr; 145(1):115-20. PubMed ID: 19183334
[TBL] [Abstract][Full Text] [Related]
9. Plasma levels of fibrinolytic proteins and the risk of myocardial infarction in men.
Meltzer ME; Doggen CJ; de Groot PG; Rosendaal FR; Lisman T
Blood; 2010 Jul; 116(4):529-36. PubMed ID: 20413657
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
Vaziri ND; Gonzales EC; Shayestehfar B; Barton CH
J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
[TBL] [Abstract][Full Text] [Related]
11. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
[TBL] [Abstract][Full Text] [Related]
12. Advances in clinical fibrinolysis.
Hessel LW; Kluft C
Clin Haematol; 1986 May; 15(2):443-63. PubMed ID: 2942332
[TBL] [Abstract][Full Text] [Related]
13. Pivotal role of plasminogen-activator inhibitor 1 in vascular disease.
Agirbasli M
Int J Clin Pract; 2005 Jan; 59(1):102-6. PubMed ID: 15707473
[TBL] [Abstract][Full Text] [Related]
14. An assessment of regional versus systemic thrombolytic treatment of peripheral and coronary artery thrombosis.
Marder VJ; Francis CW
Prog Hemost Thromb; 1984; 7():325-56. PubMed ID: 6241729
[No Abstract] [Full Text] [Related]
15. Venous stasis-induced fibrinolysis prevents thrombosis in mice: role of α2-antiplasmin.
Singh S; Houng AK; Reed GL
Blood; 2019 Sep; 134(12):970-978. PubMed ID: 31395599
[TBL] [Abstract][Full Text] [Related]
16. Assessment of fibrinolytic markers in patients with deep vein thrombosis.
Sharma S; Uppal V; Senee HK; Ahluwalia J; Das R; Varma N; Malhotra P; Kumar N
Blood Coagul Fibrinolysis; 2022 Mar; 33(2):113-118. PubMed ID: 35140191
[TBL] [Abstract][Full Text] [Related]
17. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
[TBL] [Abstract][Full Text] [Related]
18. A history of early stent thrombosis is associated with prolonged clot lysis time.
Pankiw-Bembenek O; Zalewski J; Goralczyk T; Undas A
Thromb Haemost; 2012 Mar; 107(3):513-20. PubMed ID: 22274545
[TBL] [Abstract][Full Text] [Related]
19. Fibrinolytic variables in patients with recurrent venous thrombosis: a prospective cohort study.
Crowther MA; Roberts J; Roberts R; Johnston M; Stevens P; Skingley P; Patrassi GM; Sartori MT; Hirsh J; Prandoni P; Weitz JI; Gent M; Ginsberg JS
Thromb Haemost; 2001 Mar; 85(3):390-4. PubMed ID: 11307802
[TBL] [Abstract][Full Text] [Related]
20. Increased global fibrinolytic capacity as a clue for activated fibrinolysis in pre-eclampsia.
Sucak GT; Acar K; Sucak A; Kirazli S; Haznedar R
Blood Coagul Fibrinolysis; 2006 Jul; 17(5):347-52. PubMed ID: 16788310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
